NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Income Before Tax Over TimeContracting
Percentile Rank93
3Y CAGR+29.1%
5Y CAGR+26.2%
Studio
Year-over-Year Change

Pre-tax earnings

3Y CAGR
+29.1%/yr
vs +1.1%/yr prior
5Y CAGR
+26.2%/yr
Consistent
Acceleration
+27.9pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$18.53B-19.1%
2025$22.91B+36.9%
2024$16.73B+94.2%
2023$8.62B+326.3%
2022$2.02B-65.1%
2021$5.80B+1.9%
2020$5.69B-31.0%
2019$8.25B-7.0%
2018$8.87B+42.1%
2017$6.24B-